Joseph Hargett

Joseph Hargett

Despite hailing from the Greater Cincinnati, Ohio area, Joseph Hargett has spent nearly the past decade elbow-deep in Wall Street.  Specializing in financial writing, options strategies and stock-market analysis, Joseph cut his teeth in the research department of Cincinnati-based Schaeffer’s Investment Research.

While at Schaeffer’s, Joseph wrote market, stock and options commentary for SchaeffersResearch.com, and was lead editor for The Options Advisor (the nation’s leading options newsletter).

Joseph has since moved on to become a prolific Forbes contributor in the options realm, as well as a lead copy editor and contributor for a well respected investment newsletter publisher.  Joseph’s commentary has appeared in a plethora of media outlets, including The Wall Street JournalThe New York TimesMoney Show Digest, Reuters, CBE MarketWatch and Sentiment Magazine.

Recent Articles

Trading Freeport-McMoRan Inc (FCX) Stock’s Battle with Indonesia

Freeport-McMoRan can capitalize on a spike in copper prices, and FCX stock could soar sharply, but only if the company can settle its dispute with Indonesia.

Qualcomm, Inc. (QCOM) Stock: Is the Worst Over?

Qualcomm (QCOM) has been plagued by poor earnings and lawsuits. But the worst might already be priced into QCOM stock.

Monday’s Vital Data: Nvidia Corporation (NVDA), Twitter Inc (TWTR) and Activision Blizzard, Inc. (ATVI)

Strong holiday earnings drive call options volume for Nvidia (NVDA) and Activision Blizzard (ATVI) while Twitter (TWTR) traders run for the exits.

Burned by FireEye Inc (FEYE) Stock? Try These Rebound Trades

After getting torched by earnings, FireEye (FEYE) stock traders abandoned ship. But an oversold bounce may be in the cards for FEYE stock.

Thursday’s Vital Data: Apple Inc. (AAPL), Gilead Sciences, Inc. (GILD) and Advanced Micro Devices, Inc. (AMD)

Apple (AAPL) to dole out $3.1 billion to investors, Gilead Sciences’ (GILD) has a Hep C problem and Advanced Micro Devices (AMD) rides BMO Capital note.